Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 544

1.

The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015.

Jang ES, Ki M, Choi HY, Kim KA, Jeong SH; Korean hepatitis epidemiology study group.

Hepatol Int. 2019 Aug 20. doi: 10.1007/s12072-019-09975-y. [Epub ahead of print]

PMID:
31432446
2.

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.

Kim CG, Lee HW, Choi HJ, Lee JI, Lee HW, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, Kim HS, Kim KH, Choi SJ, Kim Y, Lee KS, Kim GM, Kim MD, Won JY, Lee DY, Kim BK.

Cancer Med. 2019 Jul 10. doi: 10.1002/cam4.2417. [Epub ahead of print]

3.

Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma.

Byun HK, Kim HJ, Im YR, Kim DY, Han KH, Seong J.

Strahlenther Onkol. 2019 Jul 8. doi: 10.1007/s00066-019-01488-9. [Epub ahead of print]

PMID:
31286149
4.

Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases.

Kim KH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU.

Eur J Gastroenterol Hepatol. 2019 Jul 5. doi: 10.1097/MEG.0000000000001475. [Epub ahead of print]

PMID:
31283527
5.

Critical Limb Ischemia Induces Remodeling of Skeletal Muscle Motor Unit, Myonuclear-, and Mitochondrial-Domains.

Mohiuddin M, Lee NH, Moon JY, Han WM, Anderson SE, Choi JJ, Shin E, Nakhai SA, Tran T, Aliya B, Kim DY, Gerold A, Hansen LM, Taylor WR, Jang YC.

Sci Rep. 2019 Jul 2;9(1):9551. doi: 10.1038/s41598-019-45923-4.

6.

Factors associated with delayed emergency room visits in adult immigrant patients with mild abdominal pain in Korea.

Kim DY, Kim DH, Yoon HJ, Lee WJ, Woo SH, Seol SH, Kim HJ.

Clin Exp Emerg Med. 2019 Jun;6(2):138-143. doi: 10.15441/ceem.18.023. Epub 2019 Jun 28.

7.

Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy.

Up Kim S, Seo YS, Lee HA, Kim MN, Kim EH, Kim HY, Lee YR, Lee HW, Park JY, Kim DY, Ahn SH, Han KH, Hwang SG, Rim KS, Um SH, Tak WY, Kweon YO, Kim BK, Park SY.

Clin Gastroenterol Hepatol. 2019 Jun 25. pii: S1542-3565(19)30666-4. doi: 10.1016/j.cgh.2019.06.028. [Epub ahead of print]

PMID:
31252188
8.

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.

Kim HS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Park YN, Han DH, Kim KS, Choi JS, Choi GH, Kim HS.

Clin Mol Hepatol. 2019 Jun 27. doi: 10.3350/cmh.2018.0073. [Epub ahead of print]

9.

Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.

Lim TS, Rhee H, Kim GM, Kim SU, Kim BK, Park JY, Ahn SH, Han KH, Choi JY, Kim DY.

J Vasc Interv Radiol. 2019 Aug;30(8):1194-1200.e1. doi: 10.1016/j.jvir.2019.03.016. Epub 2019 Jun 22.

PMID:
31235408
10.

Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.

Kim DS, Lim TS, Jeon MY, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Baatarkhuu O, Kim SU.

Dig Dis Sci. 2019 Jun 11. doi: 10.1007/s10620-019-05701-8. [Epub ahead of print]

PMID:
31187326
11.

Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea.

Lee HS, Choi GH, Choi JS, Han KH, Ahn SH, Kim DY, Park JY, Kim SU, Kim SH, Yoon DS, Kim JK, Choi JW, Kim SS, Park H.

Ann Surg Treat Res. 2019 Jun;96(6):275-282. doi: 10.4174/astr.2019.96.6.275. Epub 2019 May 29.

12.

Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation.

Kim KM, Kim DY, Lee DS, Kim JW, Koh JT, Kim EJ, Jang WG.

Exp Mol Med. 2019 Jun 3;51(6):62. doi: 10.1038/s12276-019-0263-x.

13.

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B.

Shin H, Jung YW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim YY, Choi JY, Kim SU.

Clin Mol Hepatol. 2019 May 31. doi: 10.3350/cmh.2018.0103. [Epub ahead of print]

14.

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection.

Lee YJ, Heo J, Kim DY, Chung WJ, Tak WY, Kim YJ, Paik SW, Sim E, Kulasingam S, Talwani R, Haber B, Hwang P.

Clin Mol Hepatol. 2019 May 28. doi: 10.3350/cmh.2019.0006. [Epub ahead of print]

15.

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals.

Lee HW, Kim SU, Park JY, Baatarkhuu O, Kim DY, Ahn SH, Han KH, Kim BK.

Clin Transl Gastroenterol. 2019 Jun;10(6):e00036. doi: 10.14309/ctg.0000000000000036.

16.

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea.

Lee JS, Kim BK, Kim SU, Park JY, Ahn SH, Seong JS, Han KH, Kim DY.

Clin Mol Hepatol. 2019 May 20. doi: 10.3350/cmh.2018.0065. [Epub ahead of print]

17.

Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits.

Kim YY, An C, Kim DY, Aljoqiman KS, Choi JY, Kim MJ.

Ultrasonography. 2019 Jan 17. doi: 10.14366/usg.18051. [Epub ahead of print]

18.

Clinical and Echocardiographic Risk Factors Predict Late Recurrence after Radiofrequency Catheter Ablation of Atrial Fibrillation.

Kim YG, Choi JI, Boo KY, Kim DY, Oh SK, Park HS, Lee KN, Shim J, Kim JS, Park SW, Park SM, Shim WJ, Kim YH.

Sci Rep. 2019 May 3;9(1):6890. doi: 10.1038/s41598-019-43283-7.

19.

External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy.

Lee HW, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, Kim BK.

Liver Int. 2019 May 3. doi: 10.1111/liv.14129. [Epub ahead of print]

PMID:
31050379
20.

Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment

Cho SH, Shin HJ, Jung KS, Kim Y.

Turk J Haematol. 2019 May 3;36(2):106-111. doi: 10.4274/tjh.galenos.2019.2019.0306.

Supplemental Content

Loading ...
Support Center